News and Views
Nature Biotechnology 26, 655 - 656 (2008)
doi:10.1038/nbt0608-655
A new path to the cancer epigenome
Victoria M Richon1
- Victoria M. Richon is in the Department of Cancer Biology and Therapeutics, Merck Research Laboratories, Merck & Co., Inc., 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA. e-mail: victoria_richon@merck.com
Abstract
A regulator of the spatial organization of chromatin may be a promising target to curb the invasiveness of breast cancer.


